Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4631) 4631
Publication (475) 475
Newsletter (156) 156
Newspaper Article (98) 98
Book Review (87) 87
Book Chapter (53) 53
Magazine Article (37) 37
Conference Proceeding (26) 26
Book / eBook (19) 19
Dissertation (12) 12
Government Document (8) 8
Trade Publication Article (7) 7
Reference (3) 3
Report (3) 3
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3285) 3285
humans (2861) 2861
influenza (2753) 2753
animals (2336) 2336
viruses (1602) 1602
virology (1179) 1179
avian influenza (1156) 1156
health aspects (1144) 1144
pandemics (1082) 1082
infectious diseases (1080) 1080
vaccines (988) 988
female (973) 973
immunology (958) 958
influenza, human - virology (930) 930
mice (927) 927
influenza viruses (852) 852
virus diseases (841) 841
infection (799) 799
antiviral agents - pharmacology (786) 786
influenza, human - prevention & control (779) 779
influenza vaccines (761) 761
research (750) 750
microbiology (743) 743
infections (727) 727
medicine (718) 718
influenza vaccines - immunology (717) 717
analysis (697) 697
research article (679) 679
influenza, human - epidemiology (669) 669
avian flu (655) 655
vaccination (645) 645
antiviral agents (636) 636
proteins (621) 621
male (614) 614
epidemics (606) 606
multidisciplinary sciences (592) 592
influenza, human - drug therapy (544) 544
hemagglutinin (528) 528
science (526) 526
a virus (501) 501
public health (497) 497
oseltamivir (494) 494
avian influenza viruses (490) 490
dogs (473) 473
adult (472) 472
pharmacology & pharmacy (465) 465
h5n1 (455) 455
antiviral agents - therapeutic use (452) 452
mutation (452) 452
cell line (439) 439
mice, inbred balb c (436) 436
influenza a virus, h1n1 subtype - drug effects (433) 433
influenza, human - immunology (430) 430
influenza vaccines - administration & dosage (428) 428
biology (416) 416
influenza a virus (416) 416
influenza a virus, h1n1 subtype - immunology (405) 405
virus (402) 402
article (400) 400
influenza a virus, h5n1 subtype - drug effects (392) 392
influenza a virus, h5n1 subtype - immunology (390) 390
antigens (380) 380
immunization (380) 380
medicine, research & experimental (380) 380
immune response (375) 375
prevention (373) 373
middle aged (371) 371
mortality (364) 364
birds (362) 362
orthomyxoviridae infections - virology (362) 362
vaccine (344) 344
swine flu (343) 343
immunity (334) 334
immunogenicity (331) 331
replication (323) 323
medical research (315) 315
influenza virus (314) 314
adolescent (312) 312
swine influenza (311) 311
antibodies (309) 309
influenza a (309) 309
antibodies, viral - blood (307) 307
neuraminidase (305) 305
biochemistry & molecular biology (303) 303
neuraminidase - antagonists & inhibitors (303) 303
influenza in birds - virology (301) 301
drug resistance (293) 293
orthomyxoviridae infections - prevention & control (293) 293
pandemic influenza (290) 290
influenza a virus, h1n1 subtype - genetics (288) 288
orthomyxoviridae infections - immunology (287) 287
transmission (286) 286
poultry (284) 284
influenza a virus, h5n1 subtype - genetics (279) 279
lectins (279) 279
epidemiology (277) 277
in-vitro (274) 274
genetic aspects (269) 269
resistance (269) 269
oseltamivir - pharmacology (266) 266
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4950) 4950
Russian (30) 30
Chinese (11) 11
French (8) 8
German (7) 7
Japanese (2) 2
Korean (2) 2
Polish (2) 2
Spanish (2) 2
Swedish (2) 2
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets
by Sander Herfst and Eefje J. A. Schrauwen and Martin Linster and Salin Chutinimitkul and Emmie de Wit and Vincent J. Munster and Erin M. Sorrell and Theo M. Bestebroer and David F. Burke and Derek J. Smith and Guus F. Rimmelzwaan and Albert D. M. E. Osterhaus and Ron A. M. Fouchier
Science, ISSN 0036-8075, 6/2012, Volume 336, Issue 6088, pp. 1534 - 1541
Highly pathogenic avian influenza A/H5N1 virus can cause morbidity and mortality in humans but thus far has not acquired the ability to be transmitted by... 
Receptors | Inoculation | Experimental infection | Disease transmission | Pandemics | REPORTS | Viruses | Orthomyxoviridae | Ferrets | Genetic mutation | Amino acid substitution | A VIRUS | TO-PERSON TRANSMISSION | MEDIATED SELECTION | H5N1 VIRUS | HEMAGGLUTININ | MULTIDISCIPLINARY SCIENCES | HOST | INFECTION | MODEL | RECEPTOR SPECIFICITY | PATHOGENIC AVIAN INFLUENZA | Immune Sera | Reassortant Viruses - pathogenicity | Influenza A Virus, H5N1 Subtype - physiology | Poultry | Receptors, Virus - metabolism | Air Microbiology | Humans | Virulence | Molecular Sequence Data | Influenza A Virus, H5N1 Subtype - genetics | Virus Shedding | Hemagglutinin Glycoproteins, Influenza Virus - immunology | Hemagglutinin Glycoproteins, Influenza Virus - genetics | Respiratory System - virology | Female | Influenza, Human - virology | Oseltamivir - pharmacology | Disease Models, Animal | Hemagglutinin Glycoproteins, Influenza Virus - chemistry | Reverse Genetics | Antiviral Agents - pharmacology | Mutagenesis, Site-Directed | RNA Replicase - genetics | Viral Proteins - chemistry | Sialic Acids - metabolism | Viral Proteins - genetics | Influenza, Human - epidemiology | Containment of Biohazards | Influenza A Virus, H5N1 Subtype - drug effects | Influenza in Birds - epidemiology | Influenza, Human - transmission | Hemagglutinin Glycoproteins, Influenza Virus - metabolism | Animals | Orthomyxoviridae Infections - transmission | Virus Replication | RNA Replicase - chemistry | Influenza in Birds - virology | Influenza A Virus, H5N1 Subtype - pathogenicity | Mutation | Serial Passage | Orthomyxoviridae Infections - virology | Amino Acid Substitution | Avian influenza | Diseases and pests | Physiological aspects | Development and progression | Research | Animal diseases | Amino acids | Avian flu | Small mammals | Index Medicus | Polymerase | Human | Proteins | Influenza | Droplets | Genetic modification
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Adjuvanted H5N1 Vaccine Induces Early CD4⁺ T Cell Response That Predicts Long-Term Persistence of Protective Antibody Levels
by Grazia Galli and Duccio Medini and Erica Borgogni and Luisanna Zedda and Monia Bardelli and Carmine Malzone and Sandra Nuti and Simona Tavarini and Chiara Sammicheli and Anne K. Hilbert and Volker Brauer and Angelika Banzhoff and Rino Rappuoli and Giuseppe Del Giudice and Flora Castellino
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2009, Volume 106, Issue 10, pp. 3877 - 3882
Immune responses to vaccination are tested in clinical trials. This process usually requires years especially when immune memory and persistence are analyzed.... 
T lymphocytes | Influenza A virus | B lymphocytes | Vaccination | Memory | Secondary immunization | Antibodies | P values | H5N1 subtype influenza A virus | Dosage | H5N1 influenza vaccine | MF59 adjuvant | Protection | Prepandemic vaccination | Immune memory | IMMUNITY | INTERLEUKIN-4 | DESIGN | VIRUS | immune memory | MULTIDISCIPLINARY SCIENCES | protection | B-CELLS | EFFECTOR | SUPPORT | MEDIATED PROTECTION | MEMORY | prepandemic vaccination | MF59-ADJUVANTED INFLUENZA | Influenza Vaccines - administration & dosage | Adjuvants, Immunologic - administration & dosage | Adjuvants, Immunologic - pharmacology | Dose-Response Relationship, Immunologic | Humans | Neutralization Tests | Immunologic Memory - drug effects | Th1 Cells - immunology | CD4-Positive T-Lymphocytes - immunology | Polysorbates - pharmacology | Time Factors | Polysorbates - administration & dosage | Adult | Th1 Cells - drug effects | Squalene - administration & dosage | Influenza A Virus, H5N1 Subtype - drug effects | Influenza Vaccines - pharmacology | Phenotype | Influenza Vaccines - immunology | Squalene - pharmacology | Influenza A Virus, H5N1 Subtype - immunology | Antibody Formation - drug effects | Antibodies, Viral - immunology | Cell Proliferation - drug effects | Th1 Cells - cytology | CD4-Positive T-Lymphocytes - drug effects | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
by Skehel, John J and Stevens, David J and Blackburn, G. Michael and Hay, Alan J and Gamblin, Steven J and Russell, Rupert J and Haire, Lesley F and Collins, Patrick J and Lin, Yi Pu
Nature, ISSN 0028-0836, 09/2006, Volume 443, Issue 7107, pp. 45 - 49
The worldwide spread of H5N1 avian influenza has raised concerns that this virus might acquire the ability to pass readily among humans and cause a pandemic.... 
3-DIMENSIONAL STRUCTURE | POTENT | COMPLEX | MULTIDISCIPLINARY SCIENCES | SENSITIVITY | RESISTANCE | INHIBITORS | OSELTAMIVIR CARBOXYLATE | VIRUS NEURAMINIDASE | Influenza A Virus, H5N1 Subtype - enzymology | Humans | Neuraminidase - genetics | Acetamides - pharmacology | Influenza A Virus, H5N1 Subtype - classification | Influenza A Virus, H5N1 Subtype - genetics | Antiviral Agents - metabolism | Antiviral Agents - chemistry | Drug Design | Neuraminidase - chemistry | Influenza in Birds - drug therapy | Binding Sites | Neuraminidase - classification | Antiviral Agents - pharmacology | Birds - virology | Models, Molecular | Influenza A Virus, H5N1 Subtype - drug effects | Mutation - genetics | Acetamides - metabolism | Oseltamivir | Drug Resistance, Viral - genetics | Animals | Influenza in Birds - virology | Neuraminidase - antagonists & inhibitors | Protein Conformation | Enzymes | Disease transmission | Pandemics | Inhibitor drugs | Avian flu | Crystal structure
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants
by Martin, Stephen R and Gamblin, Steven J and Collins, Patrick J and Skehel, John J and Lin, Yi Pu and Hay, Alan J and Russell, Rupert J and Haire, Lesley F and Walker, Philip A and Liu, Junfeng
Nature, ISSN 0028-0836, 06/2008, Volume 453, Issue 7199, pp. 1258 - 1261
The potential impact of pandemic influenza makes effective measures to limit the spread and morbidity of virus infection a public health priority. Antiviral... 
A H5N1 | ALTER | IN-VITRO | DESIGN | VARIANTS | MULTIDISCIPLINARY SCIENCES | SENSITIVITY | SIALIC-ACID | INHIBITORS | Influenza A Virus, H5N1 Subtype - enzymology | Humans | Molecular Conformation | Drug Resistance, Viral | Neuraminidase - genetics | Crystallography, X-Ray | Influenza A Virus, H5N1 Subtype - genetics | Oseltamivir - chemistry | Enzyme Inhibitors - chemistry | Neuraminidase - chemistry | Influenza, Human - virology | Binding Sites | Influenza A Virus, H1N1 Subtype - genetics | Oseltamivir - pharmacology | Enzyme Inhibitors - metabolism | Enzyme Inhibitors - pharmacology | Models, Molecular | Neuraminidase - metabolism | Zanamivir - pharmacology | Influenza A Virus, H5N1 Subtype - drug effects | Influenza A Virus, H1N1 Subtype - drug effects | Mutation - genetics | Oseltamivir - metabolism | Influenza A Virus, H1N1 Subtype - enzymology | Protein Binding | Neuraminidase - antagonists & inhibitors | Kinetics | Influenza viruses | Properties | Microbial mutation | Proteins | Enzymes | Hydrogen bonds | Amino acids | Mutation | Drug resistance | Avian flu | Crystal structure
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Evolution of H5N1 avian influenza viruses in Asia
by Aubin, Jean-Thierry and Azebi, Saliha and Balish, Amanda and Banks, Jill and Bhat, Niranjan and Bright, Rick A and Brown, Ian and Buchy, Philippe and Burguiere, Ana-Maria and Chen, Hua-Ian and Cheng, Peter and Cox, Nancy J and Crosier, Alice and Curns, Aaron and Cuvelier, Frédèrique and Deng, Guohua and Desheva, Julia and Desvaux, Stéphanie and Diep, Nguyen Hong and Donis, Ruben O and Douglas, Alan and Dowell, Scott F and Dung, Nguyen Tien and Edwards, Lindsay and Fukuda, Keiji and Garten, Rebecca and Govorkova, Elena and Gregory, Victoria and Hampson, Alan and Hanh, Nguyen Thi Hong and Harper, Scott and Hay, Alan and Hoffmann, Erich and Hulse, Diane and Imai, Masaki and Itamura, Shigeyuki and Jadhao, Samadhan and Jeannin, Patricia and Kang, Chun and Katz, Jackie and Kim, Jae-Hong and Klimov, Alexander and Kwon, Yong-Kuk and Lee, Chang-Won and Lien, Phuong Song and Li, Yanbing and Lim, Wilina and Lin, Yi Pu and Lindstom, Stephen and Loftin, LaMorris and Mabry, Jan and Mai, Le Quynh and Maines, Taronna and Manuguerra, Jean-Claude and Mase, Masaji and Matsuoka, Yumi and McCarron, Margaret and Medina, Marie-Jo and Nguyen, Doan and Ninomiya, Ai and Obuchi, Masatsugu and Odagiri, Takato and Peiris, Malik and Perdue, Michael L and Reynes, Jean-Marc and Robertson, James and Rousseaux, Claudine and Saito, Takehiko and Sangkitporn, Somchai and Shaw, Michael and Simmerman, James M and Slomka, M and Smith, Catherine and Sorn, San and Spackman, Erica and Stöhr, Klaus and Suarez, David L and Sung, Haan Woo and Swayne, David E and Tardy-Panit, Maryse and Tashiro, Masato and Thawatsupha, Pranee and Tumpey, Terrence and Uyeki, Timothy and Van Tu, Phan and Van Der Werf, Sylvie and Vong, Sirenda and Webby, Richard and Webster, Robert and Wood, John and Xu, Xiyan and Yi, Guan and Zhang, Wenging and World Hlth Org Global Influenza Pr and World Health Organization Global Influenza Program Surveillance Network and The World Health Organization Global Influenza Program Surveillance Network
Emerging Infectious Diseases, ISSN 1080-6040, 10/2005, Volume 11, Issue 10, pp. 1515 - 1521
An outbreak of highly pathogenic avian influenza A (H5N1) has recently spread to poultry in 9 Asian countries. H5N1 infections have caused >= 52 human deaths... 
A VIRUS | SYSTEM | INFECTIOUS DISEASES | TRANSMISSION | RESCUE | HEMAGGLUTININ | 8 PLASMIDS | GENERATION | IMMUNOLOGY | REVERSE GENETICS | VACCINES | OSELTAMIVIR | Antiviral Agents - therapeutic use | Poultry | Humans | Influenza, Human - epidemiology | Influenza A Virus, H5N1 Subtype - classification | Influenza A Virus, H5N1 Subtype - drug effects | Influenza A Virus, H5N1 Subtype - genetics | Influenza in Birds - epidemiology | Phylogeny | Poultry Diseases - virology | Hemagglutinin Glycoproteins, Influenza Virus - genetics | Genetic Variation | Asia - epidemiology | Phenotype | Animals | Chickens | Influenza in Birds - virology | Influenza, Human - virology | Neuraminidase - antagonists & inhibitors | Influenza Vaccines | Influenza, Human - drug therapy | Poultry Diseases - epidemiology | Evolution, Molecular | Avian influenza | Causes of | Health aspects | Influenza in Birds | Influenza A Virus, H5N1 Subtype | Emerging diseases | Life Sciences | Animal biology | Antiviral Agents | Hemagglutinin Glycoproteins, Influenza Virus | Virology | Human health and pathology | Microbiology and Parasitology | Infectious diseases | Veterinary medicine and animal Health | Asia | Influenza, Human | Neuraminidase | Poultry Diseases | Adamantane | hemagglutinin | M2 protein | Avian | Research | NA protein | Influenza A Virus | Oseltamivir | molecular Evolution | virology | Influenza
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Determinants of Antiviral Effectiveness in Influenza Virus A Subtype H5N1
by Paul K. S. Chan and Nelson Lee and Mukhtiar Zaman and Wiku Adisasmito and Richard Coker and Wanna Hanshaoworakul and Viktor Gasimov and Ahmet Faik Oner and Nazim Dogan and Owen Tsang and Bounlay Phommasack and Sok Touch and Ebun Bamgboye and Anna Swenson and Stephen Toovey and Nancy A. Dreyer
The Journal of Infectious Diseases, ISSN 0022-1899, 11/2012, Volume 206, Issue 9, pp. 1359 - 1366
Background. Oseltamivir is widely used as treatment for influenza virus A subtype H5N1 (hereafter, "H5N1") infection but, like any intervention, is not always... 
Respiratory insufficiency | Corticosteroids | Influenza A virus | Antivirals | Patient care | Viruses | Orthomyxoviridae | Infections | H5N1 subtype influenza A virus | Symptoms | A H5N1 | INFECTIOUS DISEASES | NEURAMINIDASE INHIBITORS | HUMAN INFECTION | VIETNAM | AVIAN-INFLUENZA | HUMANS | MICROBIOLOGY | IMMUNOLOGY | Humans | Middle Aged | Child, Preschool | Respiratory Insufficiency - virology | Infant | Male | Influenza, Human - complications | Secondary Prevention | Young Adult | Influenza, Human - mortality | Adult | Female | Influenza, Human - virology | Influenza, Human - drug therapy | Child | Oseltamivir - pharmacology | Antiviral Agents - pharmacology | Respiratory Insufficiency - mortality | Treatment Outcome | Influenza A Virus, H5N1 Subtype - drug effects | Antiviral Agents - administration & dosage | Oseltamivir - administration & dosage | Adolescent | Survival Analysis | Aged | Oseltamivir phosphate | Usage | Prognosis | Research | Drug therapy | Influenza
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002–2012 shows need for continued monitoring
by Govorkova, Elena A and Baranovich, Tatiana and Seiler, Patrick and Armstrong, Jianling and Burnham, Andrew and Guan, Yi and Peiris, Malik and Webby, Richard J and Webster, Robert G
Antiviral Research, ISSN 0166-3542, 05/2013, Volume 98, Issue 2, pp. 297 - 304
► Highly pathogenic H5N1 influenza viruses are susceptible to neuraminidase inhibitors in vitro. ► A low incidence of oseltamivir-resistant markers in H5N1... 
Resistance | Oseltamivir | Amantadine | H5N1 influenza virus | Neuraminidase inhibitors | Zanamivir | INFECTIONS | CIRCULATION | ADAMANTANE RESISTANCE | AMANTADINE-RESISTANT | SUSCEPTIBILITY | SENSITIVITY | H1N1 | EMERGENCE | IN-VITRO | VIROLOGY | PHARMACOLOGY & PHARMACY | Antiviral Agents - pharmacology | Humans | Drug Resistance, Viral | Viral Proteins - genetics | Birds | Influenza A Virus, H5N1 Subtype - classification | Influenza A Virus, H5N1 Subtype - drug effects | Influenza A Virus, H5N1 Subtype - genetics | Phylogeny | Influenza A Virus, H5N1 Subtype - isolation & purification | Animals | Influenza in Birds - virology | Influenza A Virus, H5N1 Subtype - pathogenicity | Influenza, Human - virology | Virus diseases | Avian influenza | Avian influenza viruses | zanamivir | neuraminidase inhibitors | oseltamivir | resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Delayed Antiviral Plus Immunomodulator Treatment Still Reduces Mortality in Mice Infected by High Inoculum of Influenza A/H5N1 Virus
by Bo-Jian Zheng and Kwok-Wah Chan and Yong-Ping Lin and Guang-Yu Zhao and Chris Chan and Hao-Jie Zhang and Hong-Lin Chen and Samson S. Y. Wong and Susanna K. P. Lau and Patrick C. Y. Woo and Kwok-Hung Chan and Dong-Yan Jin and Kwok-Yung Yuen
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2008, Volume 105, Issue 23, pp. 8091 - 8096
The mortality of human infection by influenza A/H5N1 virus can exceed 80%. The high mortality and its poor response to the neuraminidase inhibitor oseltamivir... 
Cytokines | Lungs | Influenza A virus | Mortality | Antivirals | Viruses | Infections | H5N1 subtype influenza A virus | Viral load | Immunologic factors | Mesalazine | Celecoxib | Zanamivir | mesalazine | celecoxib | AVIAN INFLUENZA | A H5N1 VIRUS | MULTIDISCIPLINARY SCIENCES | HUMANS | OSELTAMIVIR | PATHOGENESIS | RESPONSES | INHIBITION | DISEASE | zanamivir | CORONAVIRUS | Influenza A Virus, H5N1 Subtype - physiology | Body Weight - drug effects | T-Lymphocytes - virology | Viral Load | Lung - virology | Time Factors | T-Lymphocytes - drug effects | Female | Orthomyxoviridae Infections - drug therapy | Antiviral Agents - pharmacology | Lung - pathology | Albumins - metabolism | Antiviral Agents - therapeutic use | Survival Rate | Influenza A Virus, H5N1 Subtype - drug effects | Animals | Lung - drug effects | Survival Analysis | Lymphocyte Count | Chemokines - metabolism | Mice | Mice, Inbred BALB C | Immunologic Factors - pharmacology | Immunologic Factors - therapeutic use | Prostaglandins - metabolism | Influenza viruses | Mesalamine | United States | Influence | Dosage and administration | Research | Drug therapy | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text T-705 (Favipiravir) Activity against Lethal H5N1 Influenza a Viruses
by Maki Kiso and Kazumi Takahashi and Yuko Sakai-Tagawa and Kyoko Shinya and Saori Sakabe and Quynh Mai Le and Makoto Ozawa and Yousuke Furuta and Yoshihiro Kawaoka and Mary K. Estes
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 1/2010, Volume 107, Issue 2, pp. 882 - 887
The neuraminidase inhibitors oseltamivir and zanamivi are used to treat H5N1 influenza. However, oseltamivir-resistant H5N1 viruses have been isolated from... 
Lungs | Influenza A virus | DNA | Antivirals | Viruses | Orthomyxoviridae | Infections | Mice | H5N1 subtype influenza A virus | Dosage | Murine lethal-infection model | Antiviral compounds | Neuraminidase | EFFICACY | MULTIDISCIPLINARY SCIENCES | A/VIETNAM/1203/04 H5N1 | VIRULENCE | murine lethal-infection model | IN-VITRO | NEURAMINIDASE INHIBITORS | neuraminidase | antiviral compounds | AMANTADINE | INFECTION | MICE | ORALLY-ADMINISTERED T-705 | RESISTANT INFLUENZA | Amides - pharmacology | Cell Line | Antiviral Agents - pharmacology | DNA Replication - drug effects | Humans | Drug Resistance, Viral | Influenza A Virus, H5N1 Subtype - drug effects | Kidney | Animals | Lung - drug effects | Dogs | Influenza, Human - mortality | Aged | DNA-Directed DNA Polymerase - drug effects | DNA-Directed DNA Polymerase - metabolism | Influenza, Human - drug therapy | Kinetics | Pyrazines - pharmacology | Child | Oseltamivir - pharmacology | Ribavirin - pharmacology | Influenza viruses | Antiviral agents | Swine influenza | Causes of | Research | Drug therapy | Health aspects | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text New Small Molecule Entry Inhibitors Targeting Hemagglutinin-Mediated Influenza A Virus Fusion
by Arnab Basu and Aleksandar Antanasijevic and Minxiu Wang and Bing Li and Debra M. Mills and Jessica A. Ames and Peter J. Nash and John D. Williams and Norton P. Peet and Donald T. Moir and Mark N. Prichard and Kathy A. Keith and Dale L. Barnard and Michael Caffrey and Lijun Rong and Terry L. Bowlin
Journal of Virology, ISSN 0022-538X, 02/2014, Volume 88, Issue 3, pp. 1447 - 1460
Classifications Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
MEMBRANE-FUSION | ANTIBODIES | H5N1 | VIROLOGY | PANDEMIC INFLUENZA | INFECTION | DRUG-RESISTANCE | RESISTANT INFLUENZA | H1N1 VIRUS | HEMORRHAGIC-FEVER ARENAVIRUSES | OSELTAMIVIR | Small Molecule Libraries - pharmacology | Influenza A Virus, H3N2 Subtype - drug effects | Influenza A Virus, H5N1 Subtype - physiology | Humans | Influenza A virus - genetics | Influenza A Virus, H1N1 Subtype - physiology | Influenza A Virus, H5N1 Subtype - genetics | Influenza A Virus, H3N2 Subtype - genetics | Virus Internalization - drug effects | Antiviral Agents - chemistry | Influenza, Human - virology | Influenza A Virus, H1N1 Subtype - genetics | Cell Line | Influenza A virus - physiology | Antiviral Agents - pharmacology | Hemagglutinins, Viral - metabolism | Hemagglutinins, Viral - genetics | Influenza A Virus, H5N1 Subtype - drug effects | Poultry Diseases - virology | Influenza A Virus, H1N1 Subtype - drug effects | Small Molecule Libraries - chemistry | Animals | Chickens | Influenza in Birds - virology | Influenza A Virus, H3N2 Subtype - physiology | Influenza A virus - drug effects | Vaccines and Antiviral Agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights